DOCSLIB.ORG

TOXICOLOGICAL REVIEW of CARBON TETRACHLORIDE (CAS No

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
TOXICOLOGICAL REVIEW of CARBON TETRACHLORIDE (CAS No EPA/635/R-08/005F www.epa.gov/iris TOXICOLOGICAL REVIEW OF CARBON TETRACHLORIDE (CAS No. 56-23-5) In Support of Summary Information on the Integrated Risk Information System (IRIS) March 2010 U.S. Environmental Protection Agency Washington, DC DISCLAIMER This document has been reviewed in accordance with U.S. Environmental Protection Agency policy and approved for publication. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. ii CONTENTS —TOXICOLOGICAL REVIEW OF CARBON TETRACHLORIDE (CAS No. 56-23-5) LIST OF TABLES ........................................................................................................................ vii LIST OF FIGURES ........................................................................................................................ x LIST OF ABBREVIATIONS AND ACRONYMS ..................................................................... xii FOREWARD ................................................................................................................................ xv AUTHORS, CONTRIBUTORS, AND REVIEWERS ............................................................... xvi 1. INTRODUCTION ..................................................................................................................... 1 2. CHEMICAL AND PHYSICAL INFORMATION ................................................................... 3 3. TOXICOKINETICS .................................................................................................................. 6 3.1. ABSORPTION ................................................................................................................ 6 3.1.1. Oral Exposure ....................................................................................................... 6 3.1.2. Inhalation Exposure .............................................................................................. 7 3.1.3. Dermal Exposure .................................................................................................. 7 3.2. DISTRIBUTION ............................................................................................................. 8 3.2.1. Oral Exposure ....................................................................................................... 8 3.2.2. Inhalation Exposure .............................................................................................. 8 3.2.3. Dermal Exposure ................................................................................................ 10 3.2.4. Lactational Transfer ........................................................................................... 11 3.3. METABOLISM ............................................................................................................. 11 3.4. ELIMINATION ............................................................................................................. 15 3.5. PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELS ........................... 17 4. HAZARD IDENTIFICATION ................................................................................................ 28 4.1. STUDIES IN HUMANS—EPIDEMIOLOGY, CASE REPORTS, CLINICAL CONTROLS ................................................................................................................... 28 4.1.1. Oral Exposure ..................................................................................................... 28 4.1.1.1. Human Poisoning Incidents ...................................................................... 28 4.1.1.2. Epidemiology Studies ............................................................................... 28 4.1.2. Inhalation Exposure ............................................................................................ 30 4.1.2.1. Acute Exposure Incidents ......................................................................... 30 4.1.2.2. Epidemiology Studies ............................................................................... 31 4.1.3. Dermal Exposure ................................................................................................ 38 4.2. SUBCHRONIC AND CHRONIC STUDIES AND CANCER BIOASSAYS IN ANIMALS—ORAL AND INHALATION ................................................................... 38 4.2.1. Oral Exposure ..................................................................................................... 39 4.2.1.1. Subchronic Toxicity ................................................................................. 39 4.2.1.2. Chronic Toxicity and Carcinogenicity ..................................................... 44 4.2.2. Inhalation Exposure ............................................................................................ 47 4.2.2.1. Subchronic Toxicity ................................................................................. 47 4.2.2.2. Chronic Toxicity and Carcinogenicity ..................................................... 52 iii 4.3. REPRODUCTIVE/DEVELOPMENTAL STUDIES—ORAL AND INHALATION ............................................................................................................... 63 4.3.1. Oral Exposure ..................................................................................................... 63 4.3.2. Inhalation Exposure ............................................................................................ 66 4.4. OTHER DURATION- OR ENDPOINT-SPECIFIC STUDIES ................................... 68 4.4.1. Acute and Short-term Toxicity Data .................................................................. 68 4.4.1.1. Oral Exposure ........................................................................................... 68 4.4.1.2. Inhalation Exposure .................................................................................. 70 4.4.1.3. Acute Studies Comparing Oral and Inhalation Exposures ....................... 71 4.4.2. Genotoxicity Studies .......................................................................................... 72 4.4.2.1. Genotoxicity Studies: Prokaryotic Organisms ........................................ 91 4.4.2.2. Genotoxicity Studies: Nonmammalian Eukaryotic Organisms ............... 93 4.4.2.3. Genotoxicity Studies: Mammalian Cells In Vitro ................................... 95 4.4.2.4. Genotoxicity Studies: Mammalian Cells In Vivo ................................... 98 4.4.2.5. Genotoxicity Studies: Summary of the Evidence for Genotoxic and Mutagenic Effects .................................................................................. 110 4.4.3. Initiation-promotion Studies ............................................................................ 112 4.4.4. Neurotoxicity Studies ....................................................................................... 113 4.4.5. Immunotoxicity Studies ................................................................................... 114 4.5. MECHANISTIC DATA AND OTHER STUDIES IN SUPPORT OF THE MODE OF ACTION .................................................................................................... 118 4.5.1. Metabolism is Required for Toxicity ............................................................... 118 4.5.2. Role of Free Radicals ....................................................................................... 119 4.5.3. Lipid Peroxidation ............................................................................................ 120 4.5.4. Depletion of Glutathione .................................................................................. 125 4.5.5. Disruption of Calcium Homeostasis ................................................................ 127 4.5.6. Immunological and Inflammatory Effects ....................................................... 130 4.5.7. Changes in Gene Expression ............................................................................ 132 4.5.8. Mechanisms of Kidney Toxicity ...................................................................... 133 4.6. SYNTHESIS OF MAJOR NONCANCER EFFECTS................................................ 134 4.6.1. Oral ................................................................................................................... 134 4.6.2. Inhalation .......................................................................................................... 140 4.6.3. Mode of Action Information ............................................................................ 144 4.7. EVALUATION OF CARCINOGENICITY ............................................................... 147 4.7.1. Summary of Overall Weight-of-Evidence ....................................................... 147 4.7.2. Synthesis of Human, Animal, and Other Supporting Evidence ....................... 148 4.7.3. Mode of Action Information for Liver Tumors ............................................... 151 4.7.3.1. Hypothesized Mode of Action and Identification of Key Events .......... 151 4.7.3.2. Experimental Support for the Hypothesized Mode of Action ................ 155 4.7.3.3. Other Possible Modes of Action ............................................................ 164 4.7.3.4. Conclusions About the Hypothesized Mode of Action .......................... 166 4.7.3.5. Relevance of the Hypothesized Modes of Action to Humans ................ 167 4.7.4. Mode-of-Action Information for Pheochromocytomas ................................... 167 4.8. SUSCEPTIBLE POPULATIONS AND LIFE STAGES ...........................................
Load more

Recommended publications
  • Problem Formulation of the Risk Evaluation for Perchloroethylene (Ethene, 1,1,2,2-Tetrachloro)
    EPA Document# EPA-740-R1-7017 May 2018 DRAFTUnited States Office of Chemical Safety and Environmental Protection Agency Pollution Prevention Problem Formulation of the Risk Evaluation for Perchloroethylene (Ethene, 1,1,2,2-Tetrachloro) CASRN: 127-18-4 May 2018 TABLE OF CONTENTS ABBREVIATIONS ............................................................................................................................ 8 EXECUTIVE SUMMARY .............................................................................................................. 11 1 INTRODUCTION .................................................................................................................... 14 1.1 Regulatory History ..................................................................................................................... 16 1.2 Assessment History .................................................................................................................... 16 1.3 Data and Information Collection ................................................................................................ 18 1.4 Data Screening During Problem Formulation ............................................................................ 19 2 PROBLEM FORMULATION ................................................................................................. 20 2.1 Physical and Chemical Properties .............................................................................................. 20 2.2 Conditions of Use ......................................................................................................................
    [Show full text]
  • Toxicological Profile for Carbon Tetrachloride
    CARBON TETRACHLORIDE 1 1. PUBLIC HEALTH STATEMENT This public health statement tells you about carbon tetrachloride and the effects of exposure to it. The Environmental Protection Agency (EPA) identifies the most serious hazardous waste sites in the nation. These sites are then placed on the National Priorities List (NPL) and are targeted for long-term federal clean-up activities. Carbon tetrachloride has been found in at least 430 of the 1,662 current or former NPL sites. Although the total number of NPL sites evaluated for this substance is not known, the possibility exists that the number of sites at which carbon tetrachloride is found may increase in the future as more sites are evaluated. This information is important because these sites may be sources of exposure and exposure to this substance may harm you. When a substance is released either from a large area, such as an industrial plant, or from a container, such as a drum or bottle, it enters the environment. Such a release does not always lead to exposure. You can be exposed to a substance only when you come in contact with it. You may be exposed by breathing, eating, or drinking the substance, or by skin contact. If you are exposed to carbon tetrachloride, many factors will determine whether you will be harmed. These factors include the dose (how much), the duration (how long), and how you come in contact with it. You must also consider any other chemicals you are exposed to and your age, sex, diet, family traits, lifestyle, and state of health.
    [Show full text]
  • Toxicological Profile for Tetrachloroethylene
    TETRACHLOROETHYLENE 263 6. POTENTIAL FOR HUMAN EXPOSURE 6.1 OVERVIEW Tetrachloroethylene has been identified in at least 949 of the 1,854 hazardous waste sites that have been proposed for inclusion on the EPA National Priorities List (NPL) (ATSDR 2017a). However, the number of sites evaluated for tetrachloroethylene is not known. The frequency of these sites can be seen in Figure 6-1. Of these sites, 943 are located within the United States, 3 are located in the Commonwealth of Puerto Rico (not shown), 1 is located in Guam (not shown), and 1 is located in the Virgin Islands (not shown). Tetrachloroethylene is a VOC that is widely distributed in the environment. It is released to the environment via industrial emissions and from building and consumer products. Releases are primarily to the atmosphere. However, the compound is also released to surface water and land in sewage sludges and in other liquid and solid waste, where its high vapor pressure and Henry's law constant usually result in its rapid volatilization to the atmosphere. Tetrachloroethylene has relatively low solubility in water and has medium-to-high mobility in soil; thus, its residence time in surface environments is not expected to be more than a few days. However, it persists in the atmosphere for several months and can last for decades in the groundwater. Background tetrachloroethylene levels in outdoor air are typically <1 μg/m3 (0.15 ppb) for most locations (EPA 2013h, 2018); however, indoor air at source dominant facilities (e.g., dry cleaners) has been shown to have levels >1 mg/m3 (Chiappini et al.
    [Show full text]
  • Characterization of Nudix Hydrolases: a Utilitarian
    CHARACTERIZATION OF NUDIX HYDROLASES: A UTILITARIAN SUPERFAMILY OF ENZYMES By Andres Hernandez de la Peña A dissertation submitted to the Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland August, 2015 Abstract The present work details the structural and enzymatic characterization of Nudix hydrolases from three different organisms – Bdellovibrio bacteriovorus, Mycobacterium tuberculosis, and Tetrahymena thermophila. Each of these Nudix enzymes presents unique questions about their physiological function within their organism which are answered with a combination of structural biology, genetic manipulation, enzyme kinetics, and a wide range of protein assays. We demonstrate that RenU, from M. tuberculosis, is part of Redox Homeostasis Control System (RHOCS), which senses and regulates NADH concentrations. This control systems involves two other proteins, the serine/threonine protein kinase G (pknG) and the L13 ribosomal subunits, without which the bacterium fails to evade lysosomal delivery and falls prey to the oxidative arsenal of the macrophage host. Bd-NDPSase, a Nudix enzyme encoded by the B. bacteriovorus gene BD3179, localizes to the periplasmic space of the bacterium and hydrolyses at least four nucleoside diphosphate sugars in vitro. Through atomic-resolution models from X-ray diffraction, we identified a motif that differentiates this hydrolase from the similar, but more substrate specific, ADP- ribose hydrolase from E. coli. Lastly, we show that Nud1p from T. thermophila is a member of the Ezl1p complex, the histone methyltransferase Polycomb Group homologue of this protozoan. With the use of in vitro enzymatic assays we show, in addition, that Nu1dp hydrolyses CoA preferentially over acetyl-CoA and other nucleoside derivatives.
    [Show full text]
  • 1,2-DICHLOROETHANE 1. Exposure Data
    1,2-DICHLOROETHANE Data were last reviewed in IARC (1979) and the compound was classified in IARC Monographs Supplement 7 (1987a). 1. Exposure Data 1.1 Chemical and physical data 1.1.1 Nomenclature Chem. Abstr. Serv. Reg. No.: 107-06-2 Chem. Abstr. Name: 1,2-Dichloroethane IUPAC Systematic Name: 1,2-Dichloroethane Synonym: Ethylene dichloride 1.1.2 Structural and molecular formulae and relative molecular mass Cl CH2 CH2 Cl C2H4Cl2 Relative molecular mass: 98.96 1.1.3 Chemical and physical properties of the pure substance (a) Description: Colourless liquid with a pleasant odour (Budavari, 1996) (b) Boiling-point: 83.5°C (Lide, 1995) (c) Melting-point: –35.5°C (Lide, 1995) (d) Solubility: Slightly soluble in water; miscible with ethanol, chloroform and diethyl ether (Lide, 1995; Budavari, 1996) (e) Vapour pressure: 8 kPa at 20°C (Verschueren, 1996) (f) Flash-point: 18°C, open cup (Budavari, 1996) (g) Conversion factor: mg/m3 = 4.0 × ppm 1.2 Production and use World production capacities in 1988 for 1,2-dichloroethane have been reported as follows (thousand tonnes): North America, 9445; western Europe, 9830; Japan, 3068; and other, 8351 (Snedecor, 1993). Production in the United States has been reported as follows (thousand tonnes): 1983, 5200; 1990, 6300; 1991, 6200; 1992, 6900; 1993, 8100 (United States National Library of Medicine, 1997). The total annual production in Canada in 1990 was estimated to be 922 thousand tonnes; more than 1000 thousand tonnes were produced in the United Kingdom in 1991 (WHO, 1995). –501– 502 IARC MONOGRAPHS VOLUME 71 1,2-Dichloroethane is used primarily in the production of vinyl chloride; 99% of total demand in Canada, 90% in Japan and 88% of total production in the United States are used for this purpose.
    [Show full text]
  • Association of Gene Ontology Categories with Decay Rate for Hepg2 Experiments These Tables Show Details for All Gene Ontology Categories
    Supplementary Table 1: Association of Gene Ontology Categories with Decay Rate for HepG2 Experiments These tables show details for all Gene Ontology categories. Inferences for manual classification scheme shown at the bottom. Those categories used in Figure 1A are highlighted in bold. Standard Deviations are shown in parentheses. P-values less than 1E-20 are indicated with a "0". Rate r (hour^-1) Half-life < 2hr. Decay % GO Number Category Name Probe Sets Group Non-Group Distribution p-value In-Group Non-Group Representation p-value GO:0006350 transcription 1523 0.221 (0.009) 0.127 (0.002) FASTER 0 13.1 (0.4) 4.5 (0.1) OVER 0 GO:0006351 transcription, DNA-dependent 1498 0.220 (0.009) 0.127 (0.002) FASTER 0 13.0 (0.4) 4.5 (0.1) OVER 0 GO:0006355 regulation of transcription, DNA-dependent 1163 0.230 (0.011) 0.128 (0.002) FASTER 5.00E-21 14.2 (0.5) 4.6 (0.1) OVER 0 GO:0006366 transcription from Pol II promoter 845 0.225 (0.012) 0.130 (0.002) FASTER 1.88E-14 13.0 (0.5) 4.8 (0.1) OVER 0 GO:0006139 nucleobase, nucleoside, nucleotide and nucleic acid metabolism3004 0.173 (0.006) 0.127 (0.002) FASTER 1.28E-12 8.4 (0.2) 4.5 (0.1) OVER 0 GO:0006357 regulation of transcription from Pol II promoter 487 0.231 (0.016) 0.132 (0.002) FASTER 6.05E-10 13.5 (0.6) 4.9 (0.1) OVER 0 GO:0008283 cell proliferation 625 0.189 (0.014) 0.132 (0.002) FASTER 1.95E-05 10.1 (0.6) 5.0 (0.1) OVER 1.50E-20 GO:0006513 monoubiquitination 36 0.305 (0.049) 0.134 (0.002) FASTER 2.69E-04 25.4 (4.4) 5.1 (0.1) OVER 2.04E-06 GO:0007050 cell cycle arrest 57 0.311 (0.054) 0.133 (0.002)
    [Show full text]
  • Carbon Tetrachloride
    CARBON TETRACHLORIDE Data were last reviewed in IARC (1979) and the compound was classified in IARC Monographs Supplement 7 (1987a). 1. Exposure Data 1.1 Chemical and physical data 1.1.1 Nomenclature Chem. Abstr. Serv. Reg. No.: 56-23-5 Chem. Abstr. Name: Tetrachloromethane IUPAC Systematic Name: Carbon tetrachloride Synonyms: Benzinoform; carbona 1.1.2 Structural and molecular formulae and relative molecular mass Cl Cl CCl Cl CCl4 Relative molecular mass: 153.82 1.1.3 Chemical and physical properties of the pure substance (a) Description: Colourless, clear, nonflammable, liquid with a characteristic odour (Budavari, 1996) (b) Boiling-point: 76.8°C (Lide, 1997) (c) Melting-point: –23°C (Lide, 1997) (d) Solubility: Very slightly soluble in water (0.05% by volume); miscible with benzene, chloroform, diethyl ether, carbon disulfide and ethanol (Budavari, 1996) (e) Vapour pressure: 12 kPa at 20°C; relative vapour density (air = 1), 5.3 at the boiling-point (American Conference of Governmental Industrial Hygienists, 1991) (f) Conversion factor: mg/m3 = 6.3 × ppm 1.2 Production and use Production in the United States in 1991 was reported to be approximately 143 thousand tonnes (United States International Trade Commission, 1993). Information –401– 402 IARC MONOGRAPHS VOLUME 71 available in 1995 indicated that carbon tetrachloride was produced in 24 countries (Che- mical Information Services, 1995). Carbon tetrachloride is used in the synthesis of chlorinated organic compounds, including chlorofluorocarbon refrigerants. It is also used as an agricultural fumigant and as a solvent in the production of semiconductors, in the processing of fats, oils and rubber and in laboratory applications (Lewis, 1993; Kauppinen et al., 1998).
    [Show full text]
  • Toxicological Profile for Carbon Tetrachloride
    CARBON TETRACHLORIDE 171 4. CHEMICAL AND PHYSICAL INFORMATION 4.1 CHEMICAL IDENTITY Information regarding the chemical identity of carbon tetrachloride is located in Table 4-1. 4.2 PHYSICAL AND CHEMICAL PROPERTIES Information regarding the physical and chemical properties of carbon tetrachloride is located in Table 4-2. CARBON TETRACHLORIDE 172 4. CHEMICAL AND PHYSICAL INFORMATION Table 4-1. Chemical Identity of Carbon Tetrachloride Characteristic Information Reference Chemical name Carbon tetrachloride IARC 1979 Synonym(s) Carbona; carbon chloride; carbon tet; methane tetrachloride; HSDB 2004 perchloromethane; tetrachloromethane; benzinoform Registered trade name(s) Benzinoform; Fasciolin; Flukoids; Freon 10; Halon 104; IARC 1979 Tetraform; Tetrasol Chemical formula CCl4 IARC 1979 Chemical structure Cl IARC 1979 Cl Cl Cl Identification numbers: CAS registry 56-23-5 NLM 1988 NIOSH RTECS FG4900000 HSDB 2004 EPA hazardous waste U211; D019 HSDB 2004 OHM/TADS 7216634 HSDB 2004 DOT/UN/NA/IMCO UN1846; IMCO 6.1 HSDB 2004 shipping HSDB 53 HSDB 2004 NCI No data CAS = Chemical Abstracts Service; DOT/UN/NA/IMCO = Department of Transportation/United Nations/North America/International Maritime Dangerous Goods Code; EPA = Environmental Protection Agency; HSDB = Hazardous Substances Data Bank; NCI = National Cancer Institute; NIOSH = National Institute for Occupational Safety and Health; OHM/TADS = Oil and Hazardous Materials/Technical Assistance Data System; RTECS = Registry of Toxic Effects of Chemical Substances CARBON TETRACHLORIDE 173 4. CHEMICAL
    [Show full text]
  • Product Stewardship Summary Carbon Tetrachloride
    Product Stewardship Summary Carbon Tetrachloride May 31, 2017 version Summary This Product Stewardship Summary is intended to give general information about Carbon Tetrachloride. It is not intended to provide an in-depth discussion of all health and safety information about the product or to replace any required regulatory communications. Carbon tetrachloride is a colorless liquid with a sweet smell that can be detected at low levels; however, odor is not a reliable indicator that occupational exposure levels have not been exceeded. Its chemical formula is CC14. Most emissive uses of carbon tetrachloride, a “Class I” ozone-depleting substance (ODS), have been phased out under the Montreal Protocol on Substances that Deplete the Ozone Layer (Montreal Protocol). Certain industrial uses (e.g. feedstock/intermediate, essential laboratory and analytical procedures, and process agent) are allowed under the Montreal Protocol. 1. Chemical Identity Name: carbon tetrachloride Synonyms: tetrachloromethane, methane tetrachloride, perchloromethane, benzinoform Chemical Abstracts Service (CAS) number: 56-23-5 Chemical Formula: CC14 Molecular Weight: 153.8 Carbon tetrachloride is a colorless liquid. It has a sweet odor, and is practically nonflammable at ambient temperatures. 2. Production Carbon tetrachloride can be manufactured by the chlorination of methyl chloride according to the following reaction: CH3C1+ 3C12 —> CC14 + 3HC1 Carbon tetrachloride can also be formed as a byproduct of the manufacture of chloromethanes or perchloroethylene. OxyChem manufactures carbon tetrachloride at facilities in Geismar, Louisiana and Wichita, Kansas. Page 1 of 7 3. Uses The use of carbon tetrachloride in consumer products is banned by the Consumer Product Safety Commission (CPSC), under the Federal Hazardous Substance Act (FHSA) 16 CFR 1500.17.
    [Show full text]
  • 13C NMR Study of Co-Contamination of Clays with Carbon Tetrachloride
    Environ. Sci. Technol. 1998, 32, 350-357 13 sometimes make it the equal of solid acids like zeolites or C NMR Study of Co-Contamination silica-aluminas. Benesi (7-9) measured the Hammett acidity of Clays with Carbon Tetrachloride function H0 for a number of clays; these H0 values range from +1.5 to -8.2 (in comparison to H0 )-12 for 100% ) and Benzene sulfuric acid and H0 5 for pure acetic acid). Therefore, one can expect that certain chemical transformations might occur in/on clays that are similar to what are observed in zeolite TING TAO AND GARY E. MACIEL* systems. Thus, it is of interest to examine what happens Department of Chemistry, Colorado State University, when carbon tetrachloride and benzene are ªco-contami- Fort Collins, Colorado 80523 nantsº in a clay. This kind of information would be useful in a long-term view for understanding chemical transforma- tions of contaminants in soil at contaminated sites. Data on 13 these phenomena could also be useful for designing predic- Both solid-sample and liquid-sample C NMR experiments tive models and/or effective pollution remediation strategies. have been carried out to identify the species produced by Solid-state NMR results, based on 13C detection and line the reaction between carbon tetrachloride and benzene narrowing by magic angle spinning (MAS) and high-power when adsorbed on clays, kaolinite, and montmorillonite. Liquid- 1H decoupling (10), have been reported on a variety of organic sample 13C and 1H NMR spectra of perdeuteriobenzene soil components such as humic samples (11-13). Appar- extracts confirm the identities determined by solid-sample ently, there have been few NMR studies concerned directly 13C NMR and provide quantitative measures of the amounts with elucidating the interactions of organic compounds with of the products identifiedsbenzoic acid, benzophenone, and soil or its major components.
    [Show full text]
  • Growth and Gene Expression Profile Analyses of Endometrial Cancer Cells Expressing Exogenous PTEN
    [CANCER RESEARCH 61, 3741–3749, May 1, 2001] Growth and Gene Expression Profile Analyses of Endometrial Cancer Cells Expressing Exogenous PTEN Mieko Matsushima-Nishiu, Motoko Unoki, Kenji Ono, Tatsuhiko Tsunoda, Takeo Minaguchi, Hiroyuki Kuramoto, Masato Nishida, Toyomi Satoh, Toshihiro Tanaka, and Yusuke Nakamura1 Laboratories of Molecular Medicine [M. M-N., M. U., K. O., T. M., T. Ta., Y. N.] and Genome Database [T. Ts.], Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan; Department of Obstetrics and Gynecology, School of Medicine, Kitasato University, Sagamihara 228-8555, Japan [H. K.]; Department of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba 305-8576, Japan [M. N.]; and Department of Obstetrics and Gynecology, Ibaraki Seinan Central Hospital, Tsukuba 306-0433, Japan [T. S.] ABSTRACT Akt/protein kinase B, cell survival, and cell proliferation (8). Over- expression of PTEN can decrease cell proliferation and tumorigenicity The PTEN tumor suppressor gene encodes a multifunctional phospha- (9, 10), an observation attributed to the ability of PTEN to induce cell tase that plays an important role in inhibiting the phosphatidylinositol-3- cycle arrest and apoptosis (11, 12). kinase pathway and downstream functions that include activation of Akt/protein kinase B, cell survival, and cell proliferation. Enforced ex- Thus, lack of PTEN expression may affect a complex set of pression of PTEN in various cancer cell lines decreases cell proliferation transcriptional targets. However, no systematic assessment of PTEN- through arrest of the cell cycle, accompanied in some cases by induction regulated targets in cancer cells has been reported to date.
    [Show full text]
  • Generated by SRI International Pathway Tools Version 25.0, Authors S
    Authors: Pallavi Subhraveti Ron Caspi Quang Ong Peter D Karp An online version of this diagram is available at BioCyc.org. Biosynthetic pathways are positioned in the left of the cytoplasm, degradative pathways on the right, and reactions not assigned to any pathway are in the far right of the cytoplasm. Transporters and membrane proteins are shown on the membrane. Ingrid Keseler Periplasmic (where appropriate) and extracellular reactions and proteins may also be shown. Pathways are colored according to their cellular function. Gcf_000725805Cyc: Streptomyces xanthophaeus Cellular Overview Connections between pathways are omitted for legibility.
    [Show full text]